Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression.

Khalaf, Daniel; Hilton, John F; Clemons, Mark; Azoulay, Laurent; Yin, Hui; Vandermeer, Lisa; Dent, Susan; Hopkins, Sean; Bouganim, Nathaniel

Khalaf, Daniel; Hilton, John F; Clemons, Mark; Azoulay, Laurent; Yin, Hui; Vandermeer, Lisa; Dent, Susan; Hopkins, Sean; Bouganim, Nathaniel.

Afiliação

Khalaf D; Division of Hematology-Oncology, University of Montreal - Notre-Dame Hospital, Montreal, QC H2L 4M1, Canada ; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Hilton JF; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Clemons M; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Azoulay L; Department of Oncology, Royal Victoria Hospital, McGill University, Montreal, QC H3A 1A1, Canada ; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Yin H; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Vandermeer L; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Dent S; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Hopkins S; Department of Pharmacy, The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
Bouganim N; Department of Oncology, Royal Victoria Hospital, McGill University, Montreal, QC H3A 1A1, Canada.